Britain's Health Secretary Matt Hancock said on Wednesday that AstraZeneca's decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a vaccine.
FILE PHOTO: Britain's Secretary of State for Health Matt Hancock arrives to attend a Cabinet meeting of senior government ministers at the Foreign and Commonwealth Office in London, Britain, September 1, 2020. REUTERS/Toby Melville/Pool/File Photo
LONDON - Britain’s Health Secretary Matt Hancock said on Wednesday that AstraZeneca’s decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a vaccine. AstraZeneca Plc said it had paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.
“It is obviously a challenge to this particular vaccine trial,” Hancock said on Sky News when asked about the pause in the trial. “It’s not actually the first time this has happened to the Oxford vaccine.” Asked whether it would set back the vaccine development process, he said: “Not necessarily, it depends on what they find when they do the investigation.”
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
AstraZeneca shares drop 6% after company announces 'routine' safety pause in vaccine trial
Weiterlesen »
No pandemic pause in IKEA's U.S. shopping mall plansIKEA's shopping centers business hopes to open the doors of its first mall in the United States, in the center of San Francisco, within a year, pushing ahead with its expansion plans while many retailers are reeling from the coronavirus crisis.
Weiterlesen »
AstraZeneca Pauses Covid-19 Vaccine Trial After Illness in a U.K. SubjectAstraZeneca said it paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.
Weiterlesen »
Trump's warp speed COVID vaccine plan hits snag as AstraZeneca pauses trialPhase 3 trials for AstraZeneca's COVID-19 vaccine candidate were paused Tuesday due to a 'potentially unexplained illness in one of the trials.'
Weiterlesen »
AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concernAstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant.
Weiterlesen »
AstraZeneca shares drop 6% after company announces 'routine' safety pause in vaccine trial
Weiterlesen »